Cite

HARVARD Citation

    Speed, V. et al. (2021). Fixed dose rivaroxaban can be used in extremes of bodyweight: A population pharmacokinetic analysis ‐ Reply to Jacobs & Ryan comment. Journal of thrombosis and haemostasis. pp. 872-873. [Online]. 
  
Back to record